Viscoelastic Properties of Normal and OA Chondrons
Viscoelastic Properties of Normal and OA Chondrons
批准号:
10375575
负责人:
Farshid Guilak
金额:
$49.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2024-03-31
关键词:
3-DimensionalAbbreviationsAffectApoptosisBiochemicalBiologicalBiomechanicsBiophysicsCOL6A3CartilageCell membraneCellsCharacteristicsChondrocyte-like CellChondrocytesClustered Regularly Interspaced Short Palindromic RepeatsCollagen Type VIComplexDNA Sequence AlterationDegenerative polyarthritisDevelopmentDiseaseElementsEnvironmentEpigenetic ProcessEquilibriumEventExperimental ModelsExtracellular MatrixFunctional disorderGenesGenetic TranscriptionGenetic VariationHealthHomeostasisHumanIn VitroInjuryIon ChannelIonsJointsKnock-outLeadLife StyleLiquid substanceMeasurementMechanicsMetabolicModelingMolecularMutationPathologicPharmacologyPhysical therapyPhysiologicalPlayPopulationPropertyProteinsRiskRisk FactorsRoleSecondary toSignal TransductionSolidStructureSystemTechniquesTheoretical modelTissue EngineeringTissuesarticular cartilagecartilage matrix proteincausal variantdisease-causing mutationdisorder riskearly onsetexome sequencingfunctional lossgenome editinggenome wide association studygenome-widein vitro Modelinduced pluripotent stem cellinnovationinsightmechanical loadmechanical propertiesmutantnovelregenerative therapyresponsestemsubchondral bonetranscriptomeviscoelasticity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
Osteoarthritis (OA) is a highly prevalent, disabling degenerative disease of the joints that is characterized by
progressive deleterious changes in the articular cartilage, subchondral bone, and other joint tissues. This
project will exploit emerging evidence from exome sequencing in a unique selection of (early onset) familial OA
cases that resulted in the identification of high impact mutations in COL6A3 likely causal to OA. The
mechanism by which such a mutation increases the risk for OA is unclear, partly because there is substantial
genetic variation among the population and lifestyle differences that can affect the development of OA. We
propose to develop a novel in vitro system for studying the functional effect of identified OA causal variants on
the biochemical and mechanical properties of articular cartilage using genome editing of COL6A3 in induced
pluripotent stem cells (iPSCs) and cartilage tissue engineering. Type VI collagen plays a critical role in the
function of the chondron – the chondrocyte and its surrounding pericellular matrix – which has been shown the
regulate the biological and biomechanical environment of chondrocytes in articular cartilage. We will use a
combined experimental and theoretical modeling approach to determine how changes in the physicochemical
properties of the PCM with COL6A3 mutation influence the mechanical interactions between the chondrocyte
and ECM in chondrogenically differentiated iPSCs. We will examine the early signaling events as well as the
long-term influence of COL6A3 knockout or mutation on chondrocyte response to loading. Finally, we will
examine the effect of the COL6A3 knockout or mutation on the epigenetically controlled changes of the
transcriptome of chondrocytes in response to loading. A detailed understanding of these mechanisms will
provide critical insight into the development of new pharmacologic, regenerative, or physical therapies for OA.
期刊论文(280)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1136/annrheumdis-2014-205601
发表时间:
2015-11
期刊:
Annals of the rheumatic diseases
影响因子:
27.4
作者:
[Wu CL, Jain D, McNeill JN, Little D, Anderson JA, Huebner JL, Kraus VB, Rodriguiz RM, Wetsel WC, Guilak F]
通讯作者:
Guilak F
DOI:
10.1038/srep44315
发表时间:
2017-03-20
期刊:
Scientific reports
影响因子:
4.6
作者:
[Wu CL, Kimmerling KA, Little D, Guilak F]
通讯作者:
Guilak F
DOI:
10.1016/j.joca.2011.04.011
发表时间:
2011-07
期刊:
OSTEOARTHRITIS AND CARTILAGE
影响因子:
7
作者:
[Lewis, J. S., Hembree, W. C., Furman, B. D., Tippets, L., Cattel, D., Huebner, J. L., Little, D., DeFrate, L. E., Kraus, V. B., Guilak, F., Olson, S. A.]
通讯作者:
Olson, S. A.
DOI:
10.1016/j.joca.2015.05.009
发表时间:
2015-10
期刊:
Osteoarthritis and cartilage
影响因子:
7
作者:
[Christiansen BA, Guilak F, Lockwood KA, Olson SA, Pitsillides AA, Sandell LJ, Silva MJ, van der Meulen MC, Haudenschild DR]
通讯作者:
Haudenschild DR
DOI:
10.1007/s10439-012-0598-0
发表时间:
2012-11
期刊:
ANNALS OF BIOMEDICAL ENGINEERING
影响因子:
3.8
作者:
[Halloran, J. P., Sibole, S., van Donkelaar, C. C., van Turnhout, M. C., Oomens, C. W. J., Weiss, J. A., Guilak, F., Erdemir, A.]
通讯作者:
Erdemir, A.
共 148 条
Synthetic Chronogenetic Gene Circuits for Circadian Cell Therapies
-
批准号:10797183
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2023
-
负责人:Farshid Guilak
-
依托单位:
2023 Cartilage Biology and Pathology Gordon Research Conference and Gordon Research Seminar
-
批准号:10605625
-
项目类别:
-
资助金额:$2.81万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
-
批准号:10532032
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
Deconstructing Cartilage Mechanotransduction by Piezo Channels
-
批准号:10533155
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
SMART stem cells that autonomously down-modulate TFG-β signaling for Articular Cartilage Repair
-
批准号:10371823
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
-
批准号:10707979
-
项目类别:
-
资助金额:$17.11万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
Genetically-engineered stem cells for self-regulating arthritis therapy
-
批准号:10630757
-
项目类别:
-
资助金额:$11.65万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
Genetically-engineered stem cells for self-regulating arthritis therapy
-
批准号:10598619
-
项目类别:
-
资助金额:$55.51万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
Genetically-engineered stem cells for self-regulating arthritis therapy
-
批准号:10434316
-
项目类别:
-
资助金额:$67.64万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
SMART stem cells that autonomously down-modulate TFG-β signaling for Articular Cartilage Repair
-
批准号:10590752
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
Genetically-engineered stem cells for self-regulating arthritis therapy
-
批准号:10831324
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2022
-
负责人:Farshid Guilak
-
依托单位:
Deconstructing Cartilage Mechanotransduction by Piezo Channels
-
批准号:10412358
-
项目类别:
-
资助金额:$53.55万
-
财政年份:2021
-
负责人:Farshid Guilak
-
依托单位:
Deconstructing Cartilage Mechanotransduction by Piezo Channels
-
批准号:10461211
-
项目类别:
-
资助金额:$55.48万
-
财政年份:2021
-
负责人:Farshid Guilak
-
依托单位:
Deconstructing Cartilage Mechanotransduction by Piezo Channels
-
批准号:10886368
-
项目类别:
-
资助金额:$7.34万
-
财政年份:2021
-
负责人:Farshid Guilak
-
依托单位:
Deconstructing Cartilage Mechanotransduction by Piezo Channels
-
批准号:10667476
-
项目类别:
-
资助金额:$53.13万
-
财政年份:2021
-
负责人:Farshid Guilak
-
依托单位:
Deconstructing Cartilage Mechanotransduction by Piezo Channels
-
批准号:10666726
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2021
-
负责人:Farshid Guilak
-
依托单位:
TRAINING IN REGENERATIVE MEDICINE
-
批准号:10226018
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2020
-
负责人:Farshid Guilak
-
依托单位:
TRAINING IN REGENERATIVE MEDICINE
-
批准号:10837490
-
项目类别:
-
资助金额:$16.76万
-
财政年份:2020
-
负责人:Farshid Guilak
-
依托单位:
TRAINING IN REGENERATIVE MEDICINE
-
批准号:10641329
-
项目类别:
-
资助金额:$17.11万
-
财政年份:2020
-
负责人:Farshid Guilak
-
依托单位:
TRAINING IN REGENERATIVE MEDICINE
-
批准号:10488586
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2020
-
负责人:Farshid Guilak
-
依托单位:
海外基金